Y-Clone Medical Sciences Inc. was founded in Suzhou in 2013. The company¡¯s proprietary technology is capable of inducing difficult antibodies such as broadly neutralizing antibodies against V3 region of HIV. The company focuses on developing diagnostically¡
Our technology is capable of inducing highly specific antibodies selectively against sequences of low immunogenicity, and even sequences with no immunogenicity